1. Homepage
  2. Equities
  3. Finland
  4. Nasdaq Helsinki
  5. Revenio Group Oyj
  6. News
  7. Summary
    REG1V   FI0009010912

REVENIO GROUP OYJ

(REG1V)
  Report
Delayed Nasdaq Helsinki  -  05/20 11:29:59 am EDT
46.38 EUR   +1.35%
09:01aREVENIO GROUP CORPORATION : Managers' Transactions – Heli Huopaniemi
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Arne Boye Nielsen
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Ann-Christine Sundell
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Revenio Oyj : Group Corporation has published Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement, Remuneration Report of 2020

02/23/2021 | 07:31am EDT

Revenio Group Corporation, Stock Exchange Release, February 23, 2021 at 14.30

Revenio Group Corporation’ has published Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement, Remuneration Report of 2020

Revenio Group Corporation has published Annual Report, Report by the Board of Directors and Financial Statements of 2020 in company’s internet pages, in Finnish and English at:

https://www.reveniogroup.fi/fi/sijoittajat/raportit_ja_esitykset (Finnish)

https://www.reveniogroup.fi/en/investors/reports_and_presentations (English)

The Annual Report contains an annual review, which provides information on Revenio's business and operating environment. Report by the Board of Directors and Financial Statements of 2020 contains Report by the Board of Directors and Auditor's note.

A Corporate Governance Statement has been published as part of the Annual Report 2020 at:

https://www.reveniogroup.fi/fi/sijoittajat/hallinnointi (in Finnish)

https://www.reveniogroup.fi/en/investors/corporate_governance (in English)

In addition, a separate Remuneration Report of 2020 has been published in Finnish and English at:

https://www.reveniogroup.fi/fi/sijoittajat/hallinnointi/palkitseminen (suomeksi)
https://www.reveniogroup.fi/en/investors/corporate_governance/remuneration (suomeksi)

The Annual Report, Report by the Board of Directors and Financial Statements, Corporate Governance Statement as well as the Remuneration Report are all pdf-attachments to this Stock Exchange Release.

Revenio does not publish a printed Annual Report.

Revenio Group Corporation
Board of Directors

For further information, please contact:
CFO Robin Pulkkinen, tel. +358 50 505 9932
robin.pulkkinen@revenio.fi
www.revenio.fi

DISTRIBUTION:
Nasdaq Helsinki Ltd
Financial Supervisory Authority
Main media
www.revenio.fi

Revenio Group in brief
Revenio is an internationally operating health technology corporation and a globally leading supplier of ophthalmic devices. Revenio Group's eye diagnostics solutions include tonometers, retinal imaging apparatus and perimeters under the iCare brand. The main tool for the detection and diagnosis of glaucoma and its monitoring during treatment are intraocular pressure measurement (tonometry), retinal imaging, and visual field tests (perimetry).

The Revenio Group consists of Revenio Group Corporation, Icare Finland Oy, Icare USA Inc., Revenio Italy S.R.L, CenterVue SpA, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy.

In 2020, Revenio Group's net sales totalled EUR 61.1 million, with its net operating profit standing at EUR 17.1 million. Revenio Group Corporation's shares are listed on Nasdaq Helsinki with the trading code REG1V.

© Modular Finance, source Nordic Press Releases

All news about REVENIO GROUP OYJ
09:01aREVENIO GROUP CORPORATION : Managers' Transactions – Heli Huopaniemi
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Arne Boye Nielsen
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Ann-Christine Sundell
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Bill Östman
AQ
05/11REVENIO GROUP CORPORATION : Transfer of the Company's own shares
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Riad Sherif
AQ
05/11REVENIO GROUP CORPORATION : Managers' Transactions – Pekka Tammela
AQ
04/28TRANSCRIPT : Revenio Group Oyj, Q1 2022 Earnings Call, Apr 28, 2022
CI
04/28Revenio Group Corporation's Vice Chairman has been elected
AQ
04/28Revenio Group Corporation Elects Bill Östman as Vice Chairman
CI
More news
Financials
Sales 2022 93,8 M 99,0 M 99,0 M
Net income 2022 22,1 M 23,3 M 23,3 M
Net cash 2022 11,5 M 12,1 M 12,1 M
P/E ratio 2022 55,2x
Yield 2022 0,83%
Capitalization 1 232 M 1 300 M 1 300 M
EV / Sales 2022 13,0x
EV / Sales 2023 10,8x
Nbr of Employees 184
Free-Float 80,0%
Chart REVENIO GROUP OYJ
Duration : Period :
Revenio Group Oyj Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REVENIO GROUP OYJ
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 46,38 €
Average target price 49,13 €
Spread / Average Target 5,92%
EPS Revisions
Managers and Directors
Jouni Erik Toijala President & Chief Executive Officer
Robin Allan Pulkkinen Chief Financial Officer
Arne Boye Nielsen Chairman
Mika Salkola Director-Research & Development
Ari Isomäki Operations Director
Sector and Competitors
1st jan.Capi. (M$)
REVENIO GROUP OYJ-17.62%1 287
SARTORIUS AG-35.87%23 842
BIOTAGE AB (PUBL)-27.06%1 272
VAREX IMAGING CORPORATION-29.64%884
CELLAVISION AB (PUBL)5.78%828
908 DEVICES INC.-40.82%481